US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 4.359
  • +0.034+0.79%
Close Nov 8 16:00 ET
  • 4.359
  • 0.0000.00%
Post 20:01 ET
37.70MMarket Cap-1018P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-7.40%488K
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
2.53%527K
522.52%691K
562.17%1.52M
132.73%512K
497K
Operating revenue
-7.40%488K
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
2.53%527K
522.52%691K
562.17%1.52M
132.73%512K
--497K
Cost of revenue
Gross profit
Operating expense
-18.28%8.31M
26.37%11.03M
15.20%38.67M
15.87%10.83M
11.08%8.94M
-37.10%10.17M
11.27%8.73M
6.29%33.56M
37.68%9.35M
7.34%8.05M
Selling and administrative expenses
-11.19%3.68M
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
-43.23%4.15M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
-General and administrative expense
-11.19%3.68M
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
-43.23%4.15M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
Research and development costs
-23.16%4.63M
65.90%7.25M
23.74%22.1M
36.92%6.66M
22.21%5.05M
-32.06%6.02M
3.51%4.37M
9.92%17.86M
44.66%4.86M
0.41%4.13M
Operating profit
18.87%-7.82M
-35.18%-10.86M
-14.28%-36.61M
-13.23%-10M
-18.30%-8.93M
38.40%-9.64M
-3.93%-8.04M
-2.21%-32.04M
-34.50%-8.84M
-0.71%-7.55M
Net non-operating interest income expense
-87.48%70K
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
607.59%559K
11,300.00%570K
7,183.33%874K
1,097.62%503K
14,500.00%292K
Non-operating interest income
-87.48%70K
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
607.59%559K
11,300.00%570K
7,183.33%874K
9,960.00%503K
14,500.00%292K
Other net income (expense)
62.90%202K
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
933.33%124K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
Other non- operating income (expenses)
62.90%202K
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
933.33%124K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
Income before tax
15.73%-7.55M
-42.13%-10.44M
-9.62%-34.06M
-14.49%-9.46M
-14.47%-8.3M
42.43%-8.96M
4.84%-7.35M
-0.03%-31.08M
-31.59%-8.26M
3.17%-7.25M
Income tax
0
-123.08%-29K
0
0
-29K
97.96%-13K
-13K
0
Net income
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
Net income continuous Operations
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
Minority interest income
Net income attributable to the parent company
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
Basic earnings per share
14.68%-0.93
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
41.40%-1.09
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
Diluted earnings per share
14.68%-0.93
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
41.40%-1.09
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -7.40%488K-76.12%165K34.67%2.05M61.33%826K-98.59%7K2.53%527K522.52%691K562.17%1.52M132.73%512K497K
Operating revenue -7.40%488K-76.12%165K34.67%2.05M61.33%826K-98.59%7K2.53%527K522.52%691K562.17%1.52M132.73%512K--497K
Cost of revenue
Gross profit
Operating expense -18.28%8.31M26.37%11.03M15.20%38.67M15.87%10.83M11.08%8.94M-37.10%10.17M11.27%8.73M6.29%33.56M37.68%9.35M7.34%8.05M
Selling and administrative expenses -11.19%3.68M-13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M-43.23%4.15M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M
-General and administrative expense -11.19%3.68M-13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M-43.23%4.15M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M
Research and development costs -23.16%4.63M65.90%7.25M23.74%22.1M36.92%6.66M22.21%5.05M-32.06%6.02M3.51%4.37M9.92%17.86M44.66%4.86M0.41%4.13M
Operating profit 18.87%-7.82M-35.18%-10.86M-14.28%-36.61M-13.23%-10M-18.30%-8.93M38.40%-9.64M-3.93%-8.04M-2.21%-32.04M-34.50%-8.84M-0.71%-7.55M
Net non-operating interest income expense -87.48%70K-72.28%158K113.73%1.87M-41.75%293K52.74%446K607.59%559K11,300.00%570K7,183.33%874K1,097.62%503K14,500.00%292K
Non-operating interest income -87.48%70K-72.28%158K113.73%1.87M-41.75%293K52.74%446K607.59%559K11,300.00%570K7,183.33%874K9,960.00%503K14,500.00%292K
Other net income (expense) 62.90%202K121.01%263K650.55%683K252.78%254K2,557.14%186K933.33%124K1,883.33%119K-66.17%91K-71.20%72K0.00%7K
Other non- operating income (expenses) 62.90%202K121.01%263K650.55%683K252.78%254K2,557.14%186K933.33%124K1,883.33%119K-66.17%91K-71.20%72K0.00%7K
Income before tax 15.73%-7.55M-42.13%-10.44M-9.62%-34.06M-14.49%-9.46M-14.47%-8.3M42.43%-8.96M4.84%-7.35M-0.03%-31.08M-31.59%-8.26M3.17%-7.25M
Income tax 0-123.08%-29K00-29K97.96%-13K-13K0
Net income 15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M
Net income continuous Operations 15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M
Minority interest income
Net income attributable to the parent company 15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M
Basic earnings per share 14.68%-0.93-44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.0441.40%-1.093.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86
Diluted earnings per share 14.68%-0.93-44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.0441.40%-1.093.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data